TABLE 1.
PATIENT CHARACTERISTICS FOR URINE BIOMARKER ANALYSES
| Group | Age (years) | Gender | Histology | Stage |
|---|---|---|---|---|
| Ovarian | ||||
| Healthy | Range: 49–85 | Female (n=72) | ||
| N=72 | Median: 62 | |||
| Benign | Range: 47–86 | Female (n=118) | Non-malignant neoplasms (n=41) | |
| N=118 | Median: 62 | Benign cysts (n=36) | ||
| LMP tumors (n=15) | ||||
| Other benign lesions (n=26) | ||||
| Cancer | Range: 48–87 | Female (n=108) | Serous (n=72) | I (n=5) |
| N=108 | Median: 63 | Endometrioid (n=7) | II (n=5) | |
| Mucinous (n=3) | III (n=85) | |||
| Mixed (n=19) | IV (n=13) | |||
| Undifferentiated/Unknown (n=7) | ||||
| Breast | ||||
| Healthy | Range: 49–84 | Female (n=90) | ||
| N=90* | Median: 67 | |||
| Cancer | Range: 49–92 | Female (n=74) | Ductal (n=63) | I–II (n=74) |
| N=74* | Median: 63 | Lobular (n=11) | ||
| Pancreatic | ||||
| Healthy | Range: 22–65 | Male (n=16) | ||
| N=45 | Median: 46 | Female (n=29) | ||
| Benign | Range: 32–85 | Male (n=24) | Benign cyst (n=4) | |
| N=44 | Median: 60 | Female (n=20) | Pancreatitis (n=10) | |
| Other (n=30) | ||||
| Cancer | Range: 42–91 | Male (n=36) | PDAC (n=55) | I (n=2) |
| N=55 | Median: 66 | Female (n=19) | II (n=18) | |
| III (n=13) | ||||
| IV (n=22) |
*
Includes training and validation sets; LMP, low malignant potential; PDAC, pancreatic ductal adenocarcinoma